• Je něco špatně v tomto záznamu ?

Overcoming antibiotic resistance: non-thermal plasma and antibiotics combination inhibits important pathogens

E. Vaňková, J. Julák, A. Machková, K. Obrová, A. Klančnik, S. Smole Možina, V. Scholtz

. 2024 ; 82 (-) : . [pub] 20240207

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc24014569

Grantová podpora
J4-3088 Slovenian Research and Innovation Agency

Antibiotic resistance (ATBR) is increasing every year as the overuse of antibiotics (ATBs) and the lack of newly emerging antimicrobial agents lead to an efficient pathogen escape from ATBs action. This trend is alarming and the World Health Organization warned in 2021 that ATBR could become the leading cause of death worldwide by 2050. The development of novel ATBs is not fast enough considering the situation, and alternative strategies are therefore urgently required. One such alternative may be the use of non-thermal plasma (NTP), a well-established antimicrobial agent actively used in a growing number of medical fields. Despite its efficiency, NTP alone is not always sufficient to completely eliminate pathogens. However, NTP combined with ATBs is more potent and evidence has been emerging over the last few years proving this is a robust and highly effective strategy to fight resistant pathogens. This minireview summarizes experimental research addressing the potential of the NTP-ATBs combination, particularly for inhibiting planktonic and biofilm growth and treating infections in mouse models caused by methicillin-resistant Staphylococcus aureus or Pseudomonas aeruginosa. The published studies highlight this combination as a promising solution to emerging ATBR, and further research is therefore highly desirable.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24014569
003      
CZ-PrNML
005      
20240905134252.0
007      
ta
008      
240725e20240207xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1093/femspd/ftae007 $2 doi
035    __
$a (PubMed)38730561
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Vaňková, Eva $u Department of Physics and Measurements, University of Chemistry and Technology in Prague, 160 00 Prague, Czech Republic $u Department of Biotechnology, University of Chemistry and Technology in Prague, 160 00 Prague, Czech Republic $1 https://orcid.org/0000000188630696
245    10
$a Overcoming antibiotic resistance: non-thermal plasma and antibiotics combination inhibits important pathogens / $c E. Vaňková, J. Julák, A. Machková, K. Obrová, A. Klančnik, S. Smole Možina, V. Scholtz
520    9_
$a Antibiotic resistance (ATBR) is increasing every year as the overuse of antibiotics (ATBs) and the lack of newly emerging antimicrobial agents lead to an efficient pathogen escape from ATBs action. This trend is alarming and the World Health Organization warned in 2021 that ATBR could become the leading cause of death worldwide by 2050. The development of novel ATBs is not fast enough considering the situation, and alternative strategies are therefore urgently required. One such alternative may be the use of non-thermal plasma (NTP), a well-established antimicrobial agent actively used in a growing number of medical fields. Despite its efficiency, NTP alone is not always sufficient to completely eliminate pathogens. However, NTP combined with ATBs is more potent and evidence has been emerging over the last few years proving this is a robust and highly effective strategy to fight resistant pathogens. This minireview summarizes experimental research addressing the potential of the NTP-ATBs combination, particularly for inhibiting planktonic and biofilm growth and treating infections in mouse models caused by methicillin-resistant Staphylococcus aureus or Pseudomonas aeruginosa. The published studies highlight this combination as a promising solution to emerging ATBR, and further research is therefore highly desirable.
650    12
$a antibakteriální látky $x farmakologie $x terapeutické užití $7 D000900
650    12
$a plazmové plyny $x farmakologie $7 D058626
650    _2
$a zvířata $7 D000818
650    _2
$a lidé $7 D006801
650    12
$a biofilmy $x účinky léků $7 D018441
650    _2
$a Pseudomonas aeruginosa $x účinky léků $7 D011550
650    _2
$a myši $7 D051379
650    _2
$a methicilin rezistentní Staphylococcus aureus $x účinky léků $7 D055624
650    _2
$a bakteriální léková rezistence $7 D024881
650    _2
$a antibiotická rezistence $7 D004352
650    _2
$a pseudomonádové infekce $x mikrobiologie $x farmakoterapie $7 D011552
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a stafylokokové infekce $x mikrobiologie $x farmakoterapie $7 D013203
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Julák, Jaroslav $u Department of Physics and Measurements, University of Chemistry and Technology in Prague, 160 00 Prague, Czech Republic $u Institute of Immunology and Microbiology, First Faculty of Medicine, Charles University in Prague, 160 00 Prague, Czech Republic
700    1_
$a Machková, Anna $u Department of Physics and Measurements, University of Chemistry and Technology in Prague, 160 00 Prague, Czech Republic
700    1_
$a Obrová, Klára $u Department of Physics and Measurements, University of Chemistry and Technology in Prague, 160 00 Prague, Czech Republic
700    1_
$a Klančnik, Anja $u Department of Food Science and Technology, Biotechnical Faculty, University of Ljubljana, 1000 Ljubljana, Slovenia
700    1_
$a Smole Možina, Sonja $u Department of Food Science and Technology, Biotechnical Faculty, University of Ljubljana, 1000 Ljubljana, Slovenia
700    1_
$a Scholtz, Vladimír $u Department of Physics and Measurements, University of Chemistry and Technology in Prague, 160 00 Prague, Czech Republic
773    0_
$w MED00188133 $t Pathogens and disease $x 2049-632X $g Roč. 82 (20240207)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38730561 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905134246 $b ABA008
999    __
$a ok $b bmc $g 2144001 $s 1226435
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 82 $c - $e 20240207 $i 2049-632X $m Pathogens and disease $n Pathog Dis $x MED00188133
GRA    __
$a J4-3088 $p Slovenian Research and Innovation Agency
LZP    __
$a Pubmed-20240725

Najít záznam

Citační ukazatele

Možnosti archivace